Maximus, Inc. $MMS Shares Acquired by Fort Washington Investment Advisors Inc. OH

Fort Washington Investment Advisors Inc. OH grew its stake in Maximus, Inc. (NYSE:MMS) by 36.6% in the third quarter, HoldingsChannel reports. The institutional investor owned 329,547 shares of the health services provider’s stock after buying an additional 88,284 shares during the period. Fort Washington Investment Advisors Inc. OH’s holdings in Maximus were worth $30,111,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Canada Pension Plan Investment Board acquired a new position in shares of Maximus in the 2nd quarter valued at $35,000. UMB Bank n.a. grew its stake in Maximus by 37.5% during the 2nd quarter. UMB Bank n.a. now owns 833 shares of the health services provider’s stock valued at $58,000 after purchasing an additional 227 shares during the last quarter. Bayforest Capital Ltd acquired a new position in shares of Maximus in the second quarter valued at about $61,000. Parkside Financial Bank & Trust increased its holdings in shares of Maximus by 21.7% in the second quarter. Parkside Financial Bank & Trust now owns 879 shares of the health services provider’s stock valued at $62,000 after purchasing an additional 157 shares during the period. Finally, GAMMA Investing LLC lifted its holdings in shares of Maximus by 60.4% during the second quarter. GAMMA Investing LLC now owns 1,174 shares of the health services provider’s stock worth $82,000 after purchasing an additional 442 shares during the period. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Maximus Stock Down 0.2%

Maximus stock opened at $86.86 on Wednesday. The business’s 50-day moving average price is $84.81 and its 200 day moving average price is $82.16. The company has a quick ratio of 1.64, a current ratio of 1.64 and a debt-to-equity ratio of 0.77. The firm has a market cap of $4.73 billion, a price-to-earnings ratio of 15.62 and a beta of 0.56. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $92.50.

Maximus (NYSE:MMS) last released its quarterly earnings data on Thursday, November 20th. The health services provider reported $1.62 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.01). The company had revenue of $1.32 billion during the quarter, compared to analysts’ expectations of $1.34 billion. Maximus had a return on equity of 25.23% and a net margin of 5.87%.The company’s revenue for the quarter was up .2% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.46 EPS. Maximus has set its FY 2026 guidance at 7.950-8.250 EPS. As a group, sell-side analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, December 1st. Investors of record on Friday, November 14th were given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 1.4%. The ex-dividend date was Friday, November 14th. Maximus’s dividend payout ratio (DPR) is currently 21.58%.

Insiders Place Their Bets

In other Maximus news, insider Michelle F. Link sold 4,039 shares of Maximus stock in a transaction on Wednesday, December 3rd. The shares were sold at an average price of $86.84, for a total value of $350,746.76. Following the completion of the transaction, the insider owned 19,542 shares of the company’s stock, valued at approximately $1,697,027.28. The trade was a 17.13% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.60% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently weighed in on the stock. Zacks Research downgraded shares of Maximus from a “strong-buy” rating to a “hold” rating in a report on Monday, October 27th. Weiss Ratings restated a “buy (b-)” rating on shares of Maximus in a research note on Monday. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $90.00.

About Maximus

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.